Published in Gene Therapy Weekly, March 25th, 1996
Gloria H. Frost et al. presented this surprising data at the Keystone Symposia on Tissue Engineering and Wound Repair in Context, held January 23-29, 1996 in Taos, New Mexico.
The authors noted that for successful ex vivo gene therapy, the optimal genetically engineered cell is one that is stable and produces high amounts of a therapeutic protein. In vitro expression data is used to determine which gene therapy protocol should be most effective in vivo.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.